- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.09. | Genprex Selects Andelyn Biosciences to Scale Manufacturing for Diabetes Gene Therapy Program | ||
| 03.09. | Curia Opens Expanded New Mexico Manufacturing Campus | ||
| 03.09. | PerkinElmer Completes SimoTech Acquisition | ||
| 03.09. | Genedata Expands Abcam Antibody R&D Partnership | ||
| 03.09. | Boehringer Ingelheim, Lifebit Extend Clinical Data Partnership | ||
| 02.09. | European Consortium Validates Continuous API Manufacturing Platform | ||
| 02.09. | Lifecore Strikes Tech Transfer Deal for Commercial Manufacturing of Major Pharma Company Injectable | ||
| 02.09. | Boehringer Ingelheim Licenses Owkin's K Pro AI Scientist for Accelerated Discovery in Oncology, Immunology | ||
| 02.09. | Alteogen Signs $3.2B ALT-B4 Licensing Deal With Novartis | ||
| 02.09. | Treeline, Roche Partner on TLN-121 Lymphoma Trial | ||
| 02.09. | Aurigene Signs Long-Term Manufacturing Deal With Global Pharma Company | ||
| 01.09. | FluoSphera to License Debiopharm's 3D Antibody Characterization Tech, Aided by Leica Microscope | ||
| 01.09. | Medincell Taps Edna Venneker as Chief Medical Officer | ||
| 01.09. | AstraZeneca Completes License Agreement with Dizal for Lung Cancer Treatment Zegfrovy | ||
| 01.09. | Simcere Zaiming, Roche Ink License Agreement for Antibody Targeting B-Cell-Mediated Diseases | ||
| 01.09. | Q-VANT Santiago Facility Earns EXCiPACT GMP Certification | ||
| 01.09. | BioMed X Moves HQ to Heidelberg Innovation Park | ||
| 01.09. | ElevateBio Taps Steven Falcone as COO | ||
| 01.09. | Rottendorf Pharma Begins €100M Oelde Campus Project | ||
| 31.08. | AIM ImmunoTech Extends IP Protection for Ampligen Through 2039 with Broad US Patent | ||
| 31.08. | T-Maximum Gains FDA Fast Track Status for CAR-T Glioblastoma Therapy | ||
| 31.08. | FDA Approves PharmaEssentia's Besremi for Adults with Rare Blood Cancer | ||
| 31.08. | RedHill Biopharma Divests Talicia Stake to Apotex Subsidiary for $18M | ||
| 31.08. | Lilly to Acquire Merida Biosciences for $2.875B | ||
| 28.08. | DualityBio and Genentech to Develop Next-Gen ADCs on Novel Payload Platform |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.